LGALS3 and cancer: Recent observations in a cancer xenograft model indicates that inhibition of galectin-3, using synthetic lactulosyl-1-leucine combined with taxol, reduced lung metastases and increased metastases-free animals [61]; a finding that points to increasing relevance of galectin-3 activities in human cancer.